Tag: ASPN 2024
Saluda announces presentation of two chronic pain biomarker-based analyses at ASPN...
Saluda Medical has announced the recent presentation of two abstracts analysing biomarker-based spinal cord stimulation (SCS) data at the 2024 American Society of Pain...
Boston announces clinical data from chronic pain portfolio at ASPN 2024
Boston Scientific Corporation has announced the presentation of positive five-year pooled results for the Intracept intraosseous nerve ablation system, measuring outcomes across three clinical...
